Skip to main content
Clinical Trials/NCT06256900
NCT06256900
Withdrawn
Not Applicable

Flow Controlled Ventilation to Improve Postoperative Pulmonary Outcome After Robot-assisted Laparoscopic Surgery - a Prospective, Randomised, Single-blinded, Controlled and Single-centre Investigation

Cantonal Hospital of St. Gallen0 sites774 target enrollmentOctober 29, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mechanical Ventilation Complication
Sponsor
Cantonal Hospital of St. Gallen
Enrollment
774
Primary Endpoint
Differences in the number of patients developing postoperative pulmonary complications
Status
Withdrawn
Last Updated
last year

Overview

Brief Summary

The optimization of ventilation is especially important during general anaesthesia, when active, physiologic respiration suspends and is replaced by non-physiologic mechanical positive pressure ventilation. Aiming at preserving compliance of lung tissue to guarantee an effective gas exchange is to avoid an excessive pressure application, especially in extreme positioning of the patient (Trendelenburg positioning) and/or pneumoperitoneum resulting in additional non-physiologic intrathoracic pressure. Perioperative lung protection strategies have steadily improved in recent years to reduce complications from mechanical ventilation, but postoperative pulmonary complications remain a risk factor for increased morbidity and mortality.

Detailed Description

Mechanical ventilation is crucial during general anesthesia, with ongoing efforts to refine strategies for optimal respiratory support. Important articles on perioperative ventilation explored key aspects, including PEEP application, tidal volume effects, PPC after major surgeries, and perioperative oxygen titration to mitigate oxidative stress. PEEP plays a pivotal role in enhancing oxygenation and preventing atelectasis during mechanical ventilation. Landmark studies by the ARDS Network highlight the importance of customizing PEEP application. This tailored approach not only improves respiratory mechanics but also reduces the risk of barotrauma, underscoring the crucial impact of personalized PEEP strategies. Concurrently, adopting a lung-protective strategy with low tidal volumes, has proven effective in mitigating ventilator-induced lung injury. These strategies aim to strike a balance between optimal oxygenation and minimizing potential complications associated with mechanical ventilation. Despite advancements in perioperative care, PPC remain a concern, particularly following major surgical procedures. Recent investigations emphasize the multifactorial nature of these complications. Early identification of risk factors and meticulous monitoring are crucial to reducing the incidence of complications such as atelectasis, pneumonia, and respiratory insufficiency. Understanding the interplay between mechanical ventilation strategies and postoperative outcomes is essential for improving patient recovery. The pursuit of optimal oxygenation must be balanced against the potential for oxygen toxicity and oxidative stress. Available studies shed light on the delicate equilibrium required in maintaining adequate oxygen delivery while avoiding the detrimental effects of hyperoxia. Clinicians must consider individual patient factors and tailor oxygen therapy to prevent oxidative stress, which can contribute to tissue damage and compromise overall patient well-being. FCV is a new ventilation strategy designed to minimize the mechanical effects of perioperative ventilation on lung tissue. Compared to traditionally employed ventilation strategies, gas flow is controlled during both inspiration and expiration in FCV. In particular, the almost linear pressure drop during the expiratory phase of FCV has been shown in various ex vivo/experimental and clinical studies to improve gas exchange and the proportion of ventilated lung tissue. Ongoing advancements in mechanical ventilation shape anesthesia practices with a focus on evidence-based approaches for patient safety. Building on prior findings, this study explores the benefits of the novel ventilation approach, FCV, aiming to reduce dissipative energy and alveolar stress. The investigators hypothesize positive impacts on perioperative ventilation, vital parameters, and a decreased incidence of PPC, contributing to overall postoperative morbidity and mortality reduction.

Registry
clinicaltrials.gov
Start Date
October 29, 2024
End Date
October 29, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr. Timur Yurttas

Principal Investigator, Senior Physician Anesthesiology, MD

Cantonal Hospital of St. Gallen

Eligibility Criteria

Inclusion Criteria

  • Patient undergoing elective robot-assisted laparoscopic surgery (either abdominal, urologic or gynecologic surgery) with a duration of expected ventilation of ≥ 90 minutes
  • Male or female aged ≥ 18 years
  • ASA Physical Status Classification System score I - III
  • Must be willing and able to give written informed consent to participate in the study and agree to comply with the study protocol prior to initiation of any study-mandated procedure and study intervention

Exclusion Criteria

  • Patient with weight \< 40 kg ideal body weight
  • ASA Physical Status Classification System score IV - VI
  • Previous enrolment into the current study
  • Enrolment of study investigator, his/her family members, employees and other dependent persons
  • If female and of childbearing potential: known pregnancy or a positive urine pregnancy test (confirmed by a positive serum pregnancy test), or lactating

Outcomes

Primary Outcomes

Differences in the number of patients developing postoperative pulmonary complications

Time Frame: to postoperative day 5/discharge

Development of PPC (composite endpoint including pneumonia, bronchospasm, atelectasis, pulmonary congestion, respiratory failure, pleural effusion, pneumothorax, requirement for mechanical ventilation) within the first 5 postoperative days (or until discharge). * Constant postoperative monitoring of clinical features indicating PPC * EIT parameters indicating atelectasis (defined by EIT derived parameters Global Inhomogenity Index, Tidal Impedance Variation, end-expiratory lung impedance) measurement after arrival at the PACU. * Requirement of additional oxygen will be evaluated after transfer to the PACU/ICU. Air test indicating additional oxygen requirement, SpO2 \<90% / \<88% in case of risk of hypercapnic respiratory failure. * If unplanned and continued mechanical ventilation is required after surgery this will count as fulfilled primary endpoint.

Secondary Outcomes

  • Differences in Clara-Cell 16 serum concentrations(periprocedural)
  • Differences in area under the curve of postoperative modified Horovitz index(first hour after surgery)
  • Differences in end-tidal to capillary/arterial CO2 gradient(periprocedural)
  • Differences in minimal required intraoperative FiO2 concentration(periprocedural)
  • Differences in perioperative ventilation/oxygenation parameters(periprocedural)
  • Differences in parameters derived from the electrical impedance tomography(periprocedural)

Similar Trials